Circulating tumour-cell count used to decide between treatments for breast cancer patients

Axillary radiotherapy and surgery show comparable long term outcomes for patients with breast cancer

Low-dose tamoxifen reduces recurrence and new breast disease

Adjuvant capecitabine did not significantly improve outcomes for breast cancer patients

Substituting trastuzumab emtansine for adjuvant trastuzumab improved IDFS for breast cancer patients

Two clinical trials using combination therapy in adult patients with multiple myeloma

Scalp cooling to prevent chemotherapy induced alopecia in breast cancer patients

ECHELON-2: Study into brentuximab vedotin and CHP versus CHOP in the frontline treatment of patients with T-Cell lymphomas

Results from RIALTO, blinatumomab for paediatric patients with B-cell precursor relapsed/refractory ALL

Alpha/beta T-cell and B-cell depletion haplo-HSCT is an effective treatment for children with acute leukaemia

Axicabtagene Ciloleucel in patients with refractory large B Cell lymphoma

AMG 330: an anti-CD33 bispecific T-Cell engager antibody construct in relapsed/refractory AML